INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,326 | +70.1% | 18,626 | +1.5% | 0.00% | – |
| Q2 2023 | $203,039 | +86.0% | 18,358 | +125.8% | 0.00% | – |
| Q1 2023 | $109,186 | +9.2% | 8,130 | +0.6% | 0.00% | – |
| Q4 2022 | $99,987 | -9.9% | 8,083 | +1.1% | 0.00% | – |
| Q3 2022 | $111,000 | +2.8% | 7,997 | +1.8% | 0.00% | – |
| Q2 2022 | $108,000 | -40.7% | 7,855 | -29.9% | 0.00% | – |
| Q1 2022 | $182,000 | +405.6% | 11,200 | +363.4% | 0.00% | – |
| Q3 2021 | $36,000 | +500.0% | 2,417 | +763.2% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 280 | -4.8% | 0.00% | – |
| Q1 2021 | $7,000 | -68.2% | 294 | -66.3% | 0.00% | – |
| Q4 2020 | $22,000 | -100.0% | 872 | -99.9% | 0.00% | -100.0% |
| Q3 2019 | $44,474,000 | -16.6% | 670,200 | 0.0% | 0.02% | -14.3% |
| Q2 2019 | $53,328,000 | +11.3% | 670,200 | +56.4% | 0.03% | +7.7% |
| Q1 2019 | $47,932,000 | +67.9% | 428,500 | +51.3% | 0.03% | +52.9% |
| Q4 2018 | $28,554,000 | -37.6% | 283,300 | +2.6% | 0.02% | -26.1% |
| Q3 2015 | $45,776,000 | -31.3% | 275,991 | 0.0% | 0.02% | -23.3% |
| Q2 2015 | $66,619,000 | -14.4% | 275,991 | 0.0% | 0.03% | -14.3% |
| Q1 2015 | $77,835,000 | -15.4% | 275,991 | -53.2% | 0.04% | -16.7% |
| Q4 2014 | $92,057,000 | +18.3% | 590,107 | +79.5% | 0.04% | +20.0% |
| Q3 2014 | $77,813,000 | +73.0% | 328,757 | +72.9% | 0.04% | +75.0% |
| Q2 2014 | $44,983,000 | -4.0% | 190,100 | +33.8% | 0.02% | -9.1% |
| Q1 2014 | $46,863,000 | – | 142,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |